News | May 5, 2014

DrugDev Acquires TrialNetworks To Advance The Goal Of Enabling More Efficient Clinical Trials

Source: DrugDev

As you know, DrugDev has been quite active investing and delivering transformation to the clinical trial operations process, by simplifying and removing administrative burden from the investigators.  Following the acquisition of CFS Clinical in October 2013, we are excited to now announce the acquisition of TrialNetworks. TrialNetworks' award-winning 'Clinical Trial Optimization Platform' (2014 Partnerships in Clinical Trials — Disruptive Innovator and Technology of the Year) transforms the quality, efficiency and ongoing management of clinical operations with a cloud-based suite of collaborative apps and site-facing tools. This latest acquisition expands the DrugDev family and furthers our goal to help sponsors, CROs, and sites do more trials together.  Business at DrugDev will continue to operate "as usual," but with more exciting opportunities to enhance the clinical operations process and the way in which sites collaborate with sponsors and CROs.

The Synergies of DrugDev and TrialNetworks

DrugDev and TrialNetworks have highly complementary solutions and a rich history of innovation. DrugDev, the industry's largest network of clinical research doctors, creates standardized processes to promote collaboration among sponsors, CROs and sites in finding, engaging, and paying investigators. TrialNetworks'  technology platform transforms clinical operations by simplifying the interactions with sites from study startup to closeout. TrialNetworks advances DrugDev's strength around facilitating investigator engagement and optimizing study startup with smart technology that eases the burden on investigator sites. The additional capabilities provided by TrialNetworks' innovative platform provide a unique and powerful enhancement to DrugDev's solutions.

Together, we can identify investigators for studies, initiate them faster with our combined technology platforms, then keep them engaged and motivated throughout the study with intuitive tools and timely, accurate payments. We welcome the opportunity to discuss with you any services provided by the DrugDev family of transformational companies.

For more information click here to contact DrugDev.

Source: DrugDev